The 12 de Octubre Hospital in Madrid has become a pioneer in Spain with the use of an innovative, non-invasive technique to treat non-melanoma skin cancer. This cutting-edge therapy, known as Rhenium-SCT, offers a revolutionary alternative for patients seeking effective treatments with minimal invasiveness.
The procedure utilizes the isotope Rhenium-188 to treat skin lesions without the need for surgery, significantly reducing associated risks and eliminating visible scarring. This therapy is particularly beneficial for patients with lesions in sensitive or highly visible areas, such as the face or neck.
“The Community of Madrid is leading the introduction of this technique in Spain, showcasing its commitment to innovation in skin cancer treatment,” representatives from the 12 de Octubre Hospital stated.
The application of Rhenium-SCT represents a milestone in personalized and less invasive treatments, significantly improving the quality of life for patients.
You can read the whole news here:
https://www.instagram.com/reel/DCCvJvuMESW/?igsh=MW5rMjlyajdlY3A1bg%3D%3D